MedTrace Logo

Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children

NCT05613751 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1038

Last updated 2024-01-17

No results posted yet for this study

Summary

Pregnant women and children with chronic medical conditions are at increased risk of hospitalisation, intensive care admission and death from influenza and COVID-19 infections. However, there appears to be a high level of vaccine hesitancy among women of reproductive age. We will develop "nudge" interventions to improve influenza and COVID vaccine uptake and test the effectiveness of the interventions using randomised controlled trials in

* pregnant women
* medically at risk children.

Conditions

Interventions

BEHAVIORAL

Nudge

Three text messages that are sent four weeks apart reminding to obtain the vaccines

Sponsors & Collaborators

  • University of Adelaide

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-26
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05613751 on ClinicalTrials.gov